Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia

Eye

Volumn 19, Issue 8, 2005, Pages 829-830

  Gibson, Jonathan ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

BLINDNESS; COHORT ANALYSIS; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HONG KONG; HUMAN; INDIVIDUALIZATION; LASER COAGULATION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MYOPIA; NATIONAL HEALTH SERVICE; OPHTHALMOLOGY; PATIENT CARE; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RETINA MACULA TRANSLOCATION; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; TREATMENT OUTCOME; UNITED KINGDOM; VISUAL ACUITY;

EID: 23944489887     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701680     Document Type: Editorial

References (5)

1. Ruiz-Moreno JM, Montero JA. Long term visual acuity after argon green laser photocoagulation of juxtafoveolar choroidal neovascularisation in highly myopic eyes. Eur J Ophthalmol 2002; 12: 117-122.
2. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in pathologic myopia with verteporfin: 1 year results of a randomised clinical trial - VIP report number 1. Ophthalmology 2001; 108: 841-852.
3. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularisation in pathologic myopia. 2 year results of a randomised clinical trial - VIP report number 3. Ophthalmology 2003; 110: 667-673.
4. Lam DSC, Liu DTL, Fan DSP, Lai WW, So SF, Chan W-M. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia - 1 year results of a prospective series. Eye 2005; 19(8): 834-840.
5. Verteporfin PDT Cohort Study. Guidance to Commissioners, December 2003. Royal College of Ophthalmologists: London, 2003.